139 related articles for article (PubMed ID: 216415)
1. Regulatory role of cyclic adenosine 3',5'-monophosphate on the platelet cyclooxygenase and platelet function.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1979 Jan; 582(1):44-58. PubMed ID: 216415
[TBL] [Abstract][Full Text] [Related]
2. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
[TBL] [Abstract][Full Text] [Related]
3. Cyclic AMP and platelet prostaglandin synthesis.
Gerrard JM; Peller JD; Krick TP; White JG
Prostaglandins; 1977 Jul; 14(1):39-50. PubMed ID: 197570
[TBL] [Abstract][Full Text] [Related]
4. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
Salzman EW
Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
[TBL] [Abstract][Full Text] [Related]
5. Triene prostaglandins: prostacyclin and thromboxane biosynthesis and unique biological properties.
Needleman P; Raz A; Minkes MS; Ferrendelli JA; Sprecher H
Proc Natl Acad Sci U S A; 1979 Feb; 76(2):944-8. PubMed ID: 218223
[TBL] [Abstract][Full Text] [Related]
6. A comparison of imidazole and 9,11-azoprosta-5,13-dienoic acid. Two selective thromboxane synthetase inhibitors.
Fitzpatrick FA; Gorman RR
Biochim Biophys Acta; 1978 Mar; 539(2):162-72. PubMed ID: 629996
[TBL] [Abstract][Full Text] [Related]
7. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
9. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
Gresele P; Blockmans D; Deckmyn H; Vermylen J
J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
[TBL] [Abstract][Full Text] [Related]
10. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization.
Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB
Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837
[TBL] [Abstract][Full Text] [Related]
11. Triene prostaglandins: prostaglandin D3 and icosapentaenoic acid as potential antithrombotic substances.
Whitaker MO; Wyche A; Fitzpatrick F; Sprecher H; Needleman P
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5919-23. PubMed ID: 230492
[TBL] [Abstract][Full Text] [Related]
12. Substances that increase the cyclic AMP content prevent platelet aggregation and the concurrent release of pharmacologically active substances evoked by arachidonic acid.
Vargaftig BB; Chignard M
Agents Actions; 1975 May; 5(2):137-44. PubMed ID: 51579
[TBL] [Abstract][Full Text] [Related]
13. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase.
Kowalska MA; Rao AK; Disa J
Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717
[TBL] [Abstract][Full Text] [Related]
14. Biological activity and metabolism of 20-hydroxyeicosatetraenoic acid in the human platelet.
Hill E; Fitzpatrick F; Murphy RC
Br J Pharmacol; 1992 Jun; 106(2):267-74. PubMed ID: 1327375
[TBL] [Abstract][Full Text] [Related]
15. Characterization of thromboxane receptors in human platelets.
Jones RL; Wilson NH; Armstrong RA
Adv Exp Med Biol; 1985; 192():67-81. PubMed ID: 3010674
[No Abstract] [Full Text] [Related]
16. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
Burch JW; Burch PT
Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
[TBL] [Abstract][Full Text] [Related]
17. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet aggregation by idebenone and the mechanism of the inhibition.
Suno M; Terashita Z; Nagaoka A
Arch Gerontol Geriatr; 1989 May; 8(3):313-21. PubMed ID: 2548448
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of thromboxane A2 by non-aggregating dog platelets challenged with arachidonic acid or with prostaglandin H2.
Chignard M; Vargaftig BB
Prostaglandins; 1977 Aug; 14(2):222-40. PubMed ID: 197571
[TBL] [Abstract][Full Text] [Related]
20. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
Maguire MH; Csonka-Khalifah L
Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
